Squarepoint
RVMD icon

Squarepoint’s Revolution Medicines RVMD Stock Holding History

Squarepoint’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.81M Buy
+15,000
New +$2.19M ﹤0.01% 2063
2024
Q4 		– Sell
-13,500
Closed -$612K – 5431
2024
Q3 		$612K Buy
+13,500
New +$588K ﹤0.01% 2954
2024
Q2 		– Sell
-15,000
Closed -$483K – 4562
2024
Q1 		$483K Buy
+15,000
New +$445K ﹤0.01% 3065

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Squarepoint's RVMD Position: Q2 2026 in Review

Squarepoint sold out of Revolution Medicines (RVMD) in Q2 2026, closing a stake of 120,769 shares — an estimated $17.6M sold.

Squarepoint first reported a position in RVMD in Q4 2020 and held it in 10 quarters. The position peaked at $12.5M in Q2 2025. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Squarepoint reported no remaining Revolution Medicines position as of Q2 2026 after selling out during the quarter.
  • Squarepoint sold 120,769 Revolution Medicines shares in Q2 2026, an estimated $17.6M.
  • Squarepoint first reported a position in Revolution Medicines in Q4 2020 and held it in 10 quarters.
  • Squarepoint's Revolution Medicines position peaked at $12.5M in Q2 2025.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.